🔗 Share this article

An underground market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Experimental Treatment Gaining Traction Via Social Media

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Followers are urged to contact these accounts directly for source information, while also obtaining discount codes.

Thriving Commerce on Messaging Platforms

Additionally, a robust market exists on Telegram, where communities with thousands of members share “before and after” photos, injection guides and claims of next-day British shipping. Vendors promote the drug there before directing buyers to other platforms for transactions.

Learning About Retatrutide

This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could help individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Healthcare Professionals Voice Concerns

However, physicians and pharmacists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is a cause for concern and could lead to individuals administering products of uncertain source.

Some experts said the demand for the experimental drug could be connected to the rising price of approved weight loss products such as Mounjaro.

Legal Position and Enforcement

Marketing the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unapproved medication that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Some content creators attempt to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still violate medicines, marketing, and customer laws, risking fines, prosecution or prison.

Platform Reaction and Content Elimination

According to the social media company, the platform has taken down problematic material and banned associated hashtags and search suggestions. The company stated it was committed to maintaining the service safe and investing in strengthening compliance measures.

Online Trading Operations

Research also found groups with up to nine thousand participants marketing retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” immediately displays channels with numerous of members, filled with photos of weight loss, glowing testimonials and detailed instructions for mixing or administering at residence.

After moments of joining one community, a vendor shared WhatsApp details, where the majority of purchases take place. The seller sent an guidebook and guaranteed delivery within two days. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None asked about body mass, health issues or previous experience.

Item Information and Pricing

Inside these communities, messages display dark colored packages with Royal Mail labels, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with sterile water, or ready-to-use pens typically priced at £160 for 20mg. When asked how much time a pen should last, vendors give conflicting responses varying between a few weeks to “depends on your body”.

Platform Oversight and Security Measures

A spokesperson for Telegram stated it regularly monitored harmful content on its service including material that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are administering substances they cannot confirm. Although the science behind this drug is sound, these digital versions may not include what they claim,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in interest to recent cost increases for approved slimming medications such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit treatments are highly dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she explained.

Her team has already encountered individuals harmed by self-injection from unconfirmed suppliers. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” said Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly said retatrutide was in phase 3 research studies and had not been evaluated or approved by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a Lilly investigational product not yet approved … may expose patients to potentially serious health risks”.